Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and CyclosporinDavid J. Curtis, Geoffrey R. Hill, David T Yeung et al.|New England Journal of Medicine|2025Cited by 52
Twice Daily Dosing with the Highly Specific BTK Inhibitor, Bgb-3111, Achieves Complete and Continuous BTK Occupancy in Lymph Nodes, and Is Associated with Durable Responses in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Constantine S. Tam, Andrew W. Roberts, Stephen Opat et al.|Blood|2016Cited by 37
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATGJad Othman, David Gottlieb, Matthew Greenwood et al.|Biology of Blood and Marrow Transplantation|2020Cited by 14